• Economic Evaluations Comparing a Trial of Labor with an Elective Repeat Cesarean Delivery- A Systematic Review

    Jan 1, 2017, 00:00

  • Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service

    Jan 1, 2017, 00:00

  • Reflections on ISPOR’s Clinician-Reported Outcomes Good Measurement Practice Recommendations

    Jan 1, 2017, 00:00

  • The Influence of Genotype Information on Psychiatrists’ Treatment Recommendations- More Experienced Clinicians Know Better What to Ignore

    Jan 1, 2017, 00:00

  • Assessing the Value and Implications of Personalized/Precision Medicine and the “Lessons Learned” for Emerging Technologies- An Introduction

    Jan 1, 2017, 00:00

  • The Challenge of Conditional Reimbursement- Stopping Reimbursement Can Be More Difficult Than Not Starting in the First Place!

    Jan 1, 2017, 00:00

  • Copyright/Subscription

    Jan 1, 2017, 00:00

  • Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures- An ISPOR Good Practices for Outcomes Research Task Force Report

    Jan 1, 2017, 00:00

  • In This Issue

    Jan 1, 2017, 00:00

  • Variation in Health Technology Assessment and Reimbursement Processes in Europe

    Jan 1, 2017, 00:00

  • A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease

    Jan 1, 2017, 00:00

  • Decision Making on Medical Innovations in a Changing Health Care Environment- Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies

    Jan 1, 2017, 00:00

  • Budget Impact Analysis of Prolonged Half-Life Recombinant FVIII Therapy for Hemophilia in the United States

    Jan 1, 2017, 00:00

  • “What Goes Around Comes Around”- Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine

    Jan 1, 2017, 00:00

  • Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice

    Jan 1, 2017, 00:00

  • Table of Contents

    Jan 1, 2017, 00:00

  • Estimating Preferences for Complex Health Technologies- Lessons Learned and Implications for Personalized Medicine

    Jan 1, 2017, 00:00

  • Incorporating Budget Impact Analysis in the Implementation of Complex Interventions- A Case of an Integrated Intervention for Multimorbid Patients within the CareWell Study

    Jan 1, 2017, 00:00

  • Clinician-Reported Outcome Assessments of Treatment Benefit- Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

    Jan 1, 2017, 00:00

  • Evaluation of COPD Treatments- A Multicriteria Decision Analysis of Aclidinium and Tiotropium in the United States

    Jan 1, 2017, 00:00

  • Priority to End of Life Treatments? Views of the Public in the Netherlands

    Jan 1, 2017, 00:00

  • ERRATUM

    Jan 1, 2017, 00:00

  • Costs and Outcomes of Increasing Access to Bariatric Surgery- Cohort Study and Cost-Effectiveness Analysis Using Electronic Health Records

    Jan 1, 2017, 00:00

  • New French Coverage with Evidence Development for Innovative Medical Devices- Improvements and Unresolved Issues

    Jan 1, 2017, 00:00

  • Results from a Well-Being Survey in the North West of England- Inequalities in EQ-5D–Derived Quality-Adjusted Life Expectancy Are Mainly Driven by Pain and Mental Health

    Jan 1, 2017, 00:00

  • Note to Editors

    Jan 1, 2017, 00:00

  • The Burden of Obesity on Diabetes in the United States- Medical Expenditure Panel Survey, 2008 to 2012

    Jan 1, 2017, 00:00

  • Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes- A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years

    Dec 1, 2016, 00:00

  • Reviewer Acknowledgement

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland

    Dec 1, 2016, 00:00

  • Economic Evaluations of Multicomponent Disease Management Programs with Markov Models- A Systematic Review

    Dec 1, 2016, 00:00

  • The Cost of Costing Treatments Incorrectly- Errors in the Application of Drug Prices in Economic Evaluation Due to Failing to Account for the Distribution of Patient Weight

    Dec 1, 2016, 00:00

  • Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States

    Dec 1, 2016, 00:00

  • EQ-5D Scores for Diabetes-Related Comorbidities

    Dec 1, 2016, 00:00

  • Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants

    Dec 1, 2016, 00:00

  • Making Choices on the Journey to Universal Health Care Coverage- From Advocacy to Analysis

    Dec 1, 2016, 00:00

  • Instructions for Authors

    Dec 1, 2016, 00:00

  • Health Economics as Rhetoric- The Limited Impact of Health Economics on Funding Decisions in Four European Countries

    Dec 1, 2016, 00:00

  • Editorial Board

    Dec 1, 2016, 00:00

  • From the Co-Editors-In-Chief

    Dec 1, 2016, 00:00

  • Table of Contents

    Dec 1, 2016, 00:00

  • How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America

    Dec 1, 2016, 00:00

  • Country-Level Cost-Effectiveness Thresholds- Initial Estimates and the Need for Further Research

    Dec 1, 2016, 00:00

  • Translating Pharmacometrics to a Pharmacoeconomic Model of COPD

    Dec 1, 2016, 00:00

  • The International Decision Support Initiative Reference Case for Economic Evaluation- An Aid to Thought

    Dec 1, 2016, 00:00

  • Update to the Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for Five Health-Related Quality-of-Life Scores

    Dec 1, 2016, 00:00

  • Arbitration Board Setting Reimbursement Amounts for Pharmaceutical Innovations in Germany When Price Negations between Payers and Manufacturers Fail- An Empirical Analysis of 5 Years’ Experience

    Dec 1, 2016, 00:00

  • Cancer Care Coordinators to Improve Tamoxifen Persistence in Breast Cancer- How Heterogeneity in Baseline Prognosis Impacts on Cost-Effectiveness

    Dec 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Nivolumab Compared with Ipilimumab for the Treatment of BRAF Wild-Type Advanced Melanoma in Australia

    Dec 1, 2016, 00:00

  • A Differential Item Functioning Analysis of the EQ-5D in Cancer

    Dec 1, 2016, 00:00

  • Copyright/Subscription

    Dec 1, 2016, 00:00

  • ERRATUM

    Dec 1, 2016, 00:00

  • Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment

    Dec 1, 2016, 00:00

  • Using Patient-Reported Outcomes for Economic Evaluation- Getting the Timing Right

    Dec 1, 2016, 00:00

  • Node-Splitting Generalized Linear Mixed Models for Evaluation of Inconsistency in Network Meta-Analysis

    Dec 1, 2016, 00:00

  • Benefits of Quitting Smoking in Japan on Working Productivity and Activity Impairment and Indirect Costs

    Nov 1, 2016, 00:00

  • Relapse Rates and Symptom Management Among Patients Receiving Natalizumab and other Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Identifying the Key Parameters of the European-Study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) Model

    Nov 1, 2016, 00:00

  • Clinical and Economic Benefits of a Community Pharmacy Vaccination Strategy

    Nov 1, 2016, 00:00

  • Policy Evaluation on“The Pay-For-Performance Program of Hepatitis B and C” in Taiwan

    Nov 1, 2016, 00:00

  • Development of An Alcohol Policy Model That Predicts Life Years, Qalys, and Health Care Costs Accounting for Alcohol use Disorder Identification Test

    Nov 1, 2016, 00:00

  • Incorporating Biometric Data from Wearable Activity Trackers with Study Data in France and the UK

    Nov 1, 2016, 00:00

  • Barriers To Intravitreal Injection Therapy Adherence In Dme Patients In Australia

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of whole-Exome Sequencing in Complex Paediatric Neurology

    Nov 1, 2016, 00:00

  • Factors Influencing Attitudes to Colorectal Cancer Screening

    Nov 1, 2016, 00:00

  • Innovative Approach To Keeping Evidence Current And Guidelines Living

    Nov 1, 2016, 00:00

  • The Comparisons of Biologics with Methotrexate for Treating Rheumatoid Arthritis Patients in Taiwan- The use of Cost-Utility Analysis and Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Impact of Safety-Related Regulation on Use of Codeine in Taiwanese Children

    Nov 1, 2016, 00:00

  • One-Year Follow-Up of Medication Regimen Complexity Among Moderate Copd Patients with or Without Earlier Use Of Inhaled Corticosteroids

    Nov 1, 2016, 00:00

  • Methods for Time-Varying Exposure – A Literature Review

    Nov 1, 2016, 00:00

  • The Effect of Reducing Cost-Sharing for Children on Utilization of Inpatient Services- Evidence From Japan

    Nov 1, 2016, 00:00

  • Effectiveness of A Renal Protection Program In Patients with Hypertension and/or Diabetes Mellitus Type II In Colombia

    Nov 1, 2016, 00:00

  • Why is the Herd Protection Level Higher in the UK than in Belgium after the Introduction of the Rotavirus Vaccine?

    Nov 1, 2016, 00:00

  • Measuring Income-Related Inequity In Self-Assessed Health Using The EQ-5D In 7 Countries

    Nov 1, 2016, 00:00

  • Comparison of Health Care Utilization And Cost Depending on The Severity of Asthma in Adults- Analysis of The Korean National Health Insurance Claims Database

    Nov 1, 2016, 00:00

  • Cost-Effectiveness and Cost-Utility of Intralesional Recombinant Human Epidermal Growth Factor for Adjuvant Treatment of Wagner’s 3 and 4 Diabetic Foot Ulcers

    Nov 1, 2016, 00:00

  • Contrasting The Characteristics Of Hta Submissions For Rare Versus Ultra-Rare Diseases

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Xydalba from the Perspective of Italian National Health System

    Nov 1, 2016, 00:00

  • Concentration Analysis Of Hungarian Health Care Providers Between 2006-2015

    Nov 1, 2016, 00:00

  • Indications For Prescription of Immodin®, Its Efficacy And Effect on The Most Commonly Examined Immunological Parameters

    Nov 1, 2016, 00:00

  • The Impact of Ischemic Stroke on Atrial Fibrillation-Related Healthcare Cost- A Systematic Review

    Nov 1, 2016, 00:00

  • Cost Minimization Of 10% Intravenous Immunoglobulin Against Other Intravenous Immunoglobulin For Treating Primary Inmunodeficiencies

    Nov 1, 2016, 00:00

  • The Influence of Glycemic Control in the Quality of Life of Type 2 Diabetes Mellitus Patients in Greece-the Hypo2 Study

    Nov 1, 2016, 00:00

  • The Prevalence of Plaque Psoriasis, Psoriatic Arthritis And The Overlap Between Them In Norway

    Nov 1, 2016, 00:00

  • The Economic Impact of Early Exit From Work Attributable To Osteoarthritis

    Nov 1, 2016, 00:00

  • Cost Effectiveness Evaluation of Fracture Liaison Services for the Management of Osteoporosis in Sweden

    Nov 1, 2016, 00:00

  • Tocilizumab Monotherapy As The First Line of Biological Treatment In Rheumatoid Arthritis- Budget Impact Analyses From The Perspective of Brazilian Public Healthcare System (SUS)

    Nov 1, 2016, 00:00

  • Are us Private Payers' Medical Policies Influenced by Cochrane Evidence?

    Nov 1, 2016, 00:00

  • Retrospective Claims Database Analysis to Explore Differences in Heart Failure Patients with and without Iron Deficiency or Anemia

    Nov 1, 2016, 00:00

  • Cost Of Dengue And Cost-Effectiveness Of The Dengue Vaccine In Panama

    Nov 1, 2016, 00:00

  • Hepatitis B Vaccination in Dialysis Patients. Is it Really Protective?

    Nov 1, 2016, 00:00

  • Rare Disease Treatment Recommendations in the UK- What Limitations and Requests are Imposed as Part of Nice HST Guidance?

    Nov 1, 2016, 00:00

  • A Systematic Literature Review On The Drivers of Effectiveness and The Efficacy-Effectiveness Gap in Hematological Malignancies with A Focus On Hodgkin’s Lymphoma

    Nov 1, 2016, 00:00

  • A Cohort Study to Access the Impact of Paediatric Use of Proton Pomp Inhibitor on the Risk of Community Acquired Infections €“ Utopie

    Nov 1, 2016, 00:00

  • Non-Invasive Vagus Nerve Stimulation As A Treatment For Headache Patients with Multi-Morbidity- Real World Experience In English Primary Care

    Nov 1, 2016, 00:00

  • Long-Term Follow-Up of Ranibizumab Treated Patients with Myopic Choroidal Neovascularization from the Radiance Clinical Trial in Four East Asian Countries

    Nov 1, 2016, 00:00

  • Appropriate Analysis of the Additional Costs of Antibiotic Resistan The Impact of Different Biases

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Including A Pentavalent (Hib-Hbv-Dtp) Vaccine In The National Childhood Immunization Schedule Of Iran

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Overactive Bladder Treatment with Mirabegron in Patients in South Korea

    Nov 1, 2016, 00:00

  • Value Added Medicines- The Need To Establish One Common Terminology For Repurposed Medicines

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of The Use of Extended Half-Life Recombinant Factor VIII (EFMOROCTOG ALFA) For The Treatment of Congenital Haemophilia A- The Italian National Health System Perspective

    Nov 1, 2016, 00:00

  • Valuing Cancer-Related Premature Mortality- A Comparison of Consumer-Led Versus Producer-Led Approaches

    Nov 1, 2016, 00:00

  • Can Acute Phase Clinical Outcomes Predict Health-Related Quality of Life After Stroke?

    Nov 1, 2016, 00:00

  • Systematic Literature Review of Utility Data For House Dust Mite-Induced Allergic Asthma and/or Allergic Rhinitis

    Nov 1, 2016, 00:00

  • Challenges in the Health Economics of Acute Pain- A Rapid Review of the Literature

    Nov 1, 2016, 00:00

  • Systematic Review of Cost-Effectiveness Models in Diabetes for Insulin Analogues

    Nov 1, 2016, 00:00

  • Considerations in Meta-Analytic Network Design- The Case of Platinum Doublet Chemotherapies in Advanced Non-Small Cell Lung Cancer (Advnsclc)

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Nivolumab in Combination with Ipilimumab for the Treatment of Advanced Melanoma Patients in England

    Nov 1, 2016, 00:00

  • Italian Electronic Health Records Mapping- Is Clinical Data Collection Getting In Line With The Real World Evidence Era?

    Nov 1, 2016, 00:00

  • Value of Expanding Hcv Treatment Capacity in Germany Through Novel, Effective and Shorter Duration Therapies

    Nov 1, 2016, 00:00

  • Innovative Medical Device Design Significantly Reduces Surgeon Intra-Procedural Stress Levels (Ipsl)

    Nov 1, 2016, 00:00

  • Cost-Efficiency Of Medication Safety Program At Pediatrics, Obstetrics, And Gynecology Hospital, East Province, Saudi Arabia

    Nov 1, 2016, 00:00

  • Treatment Patterns And Healthcare Costs of Rheumatoid Arthritis (RA) Patients In Italy

    Nov 1, 2016, 00:00

  • Investigation About Influence Of Management Strategy In National Hospital Organization (Nho) Hospitals By The Revision Of Medical Fee Schedule

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Nivolumab Monotherapy for the Treatment of Advanced Melanoma Patients in the United Kingdom

    Nov 1, 2016, 00:00

  • Comparison Of Web-Based Signal Detection Using Medical Forums Data In France From 2005-2015 With Signals From Vigibase®

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Ibrutinib in Adult Patients with Relapsed Chronic Lymphocytic Leukaemia in the Netherlands

    Nov 1, 2016, 00:00

  • Health Technology Assessment In Brazil- Metrics From The Reports Of The National Commission For Incorporation Of Technologies (Conitec)

    Nov 1, 2016, 00:00

  • Severe ulcerative collitis in children and adolescents in poland – it’s time to catch up with Europe. Budget impact analysis (Bia) for biosimilar infliximab

    Nov 1, 2016, 00:00

  • Cost Effectiveness Of Ivacaftor And Lumacaftor Combination For The Treatment Of Patients With Cystic Fibrosis In The United States

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Dapagliflozin Versus Acarbose as A Monotherapy in Type 2 Diabetes in China

    Nov 1, 2016, 00:00

  • Comparison Between Cancer Drugs Assessment In Portugal And United Kingdom

    Nov 1, 2016, 00:00

  • An a Priori Decision Criteria Elicitation Method for Treatment Decision-Making in Elderly Colorectal Cancer Patients

    Nov 1, 2016, 00:00

  • Risk of Mortality and Hospital Readmission Among Older Adults with Heart Failure Treated with Carvedilol, Bisoprolol or Metoprolol Tartrate

    Nov 1, 2016, 00:00

  • Atrial Fibrillation- Evidence Generation and Practice Improvement. Real World Evidence From Italian Administrative Databases

    Nov 1, 2016, 00:00

  • How time and severity increases the overall cost and resource utilization of patient with severe liver disease. Main burdens and consequences to health system

    Nov 1, 2016, 00:00

  • Managed Access Agreements- A New Model Pathway for The Reimbursement of Non-Oncology Drugs in England Approved Under European Adaptive Pathways?

    Nov 1, 2016, 00:00

  • Health Care Costs, Lenght Of Stay And Mortality Of Carbapenem Resistance Gram-Negative Bacteremia

    Nov 1, 2016, 00:00

  • Defining the Value- Do the New Oncology Frameworks in the Us Aim at Objective Valuation? – A Case Study in Multiple Myeloma

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of A Bone Transplant Fixation “Shark Screw” Transplant Compared To Metal Devices In Oesteosynthesis In Austria

    Nov 1, 2016, 00:00

  • Nationwide Survey on The Opinions of Cancer Patients and Personnel on Cost of Metastatic Colorectal Cancer Treatment

    Nov 1, 2016, 00:00

  • A Systematic Literature Review (Slr) of Health-Economic Evaluations of Treatments for Rare Diseases

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Alemtuzumab Versus Natalizumab For The Treatment Of Relapsing-Remitting Multiple Sclerosis- Us Payer Perspective

    Nov 1, 2016, 00:00

  • Cost of Treatment of Pancreas Transplantation Therapy and Insulin Pump Therapy of Type I Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Health Related Quality of Life of Hidradenitis Suppurativa Patients in Finland

    Nov 1, 2016, 00:00

  • Are Criteria Commonly Used in the Benefit Assessment of Drugs also Applicable to Medical Devices? - A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Cardiovascular Events of Patients Presenting with Peripheral Artery Disease (PAD)- An Epidemiological Analysis Using a Claims Database in France

    Nov 1, 2016, 00:00

  • Clinical and Economic Analysis of Eyelid Hygiene Complex for Patients with Meibomian Glands Dysfunction in Russia

    Nov 1, 2016, 00:00

  • Low-Density Lipoprotein Cholesterol Lowering Efficacy of Evolocumab May Reduce Need for Apheresis in Heterozygous Familial Hypercholesterolaemia Patients According to Russian Guidelines

    Nov 1, 2016, 00:00

  • Cost-Efffectivenes of Sonidegib Versus Vismodegib for The Treatment of Patients with Locally Advanced Basal Cell Carcinoma Not Amenable to Surgery or Radiotherapy

    Nov 1, 2016, 00:00

  • Extension Of The Labels Within The Eq-5d-Y

    Nov 1, 2016, 00:00

  • A Health Technology Assessment of Single Balloon Valvuplasty

    Nov 1, 2016, 00:00

  • Estimating The Cost of End-Stage Renal Disease to The Hospital System in SingaporeSidharta SD*1, Yang F2, Yoong JS1

    Nov 1, 2016, 00:00

  • Prevalence and Characteristics of Mental Disorders Among Hospitalized Breast Cancer Patients in the United States

    Nov 1, 2016, 00:00

  • Translation of Chinese Version of Measure Yourself Medical Outcome Profile (MYMOP) And Application In The Coronary Heart Disease

    Nov 1, 2016, 00:00

  • Patient Focused Technology Enabled Programs Improve Outcomes in Primary Total Hip (THA) Total Knee Arthroplasty (TKA) Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rivaroxaban Within Subgroups for Atrial Fibrillation and Venous Thromboembolism in The Netherlands

    Nov 1, 2016, 00:00

  • Reliability of Manufacturers’ Budget Impact Estimates For Melanoma Drugs in Poland

    Nov 1, 2016, 00:00

  • Development of a Global Model for the Economic Evaluation of Personalized Medicine for the Treatment of Prostate Cancer

    Nov 1, 2016, 00:00

  • Safety And Effectiveness of Autologous Platelet Rich Plasma Therapy For Lateral Epicondylitis- Systematic Reviews

    Nov 1, 2016, 00:00

  • Real-World Outcomes of Patients with Metastatic Merkel Cell Carcinoma Treated with Second-Line or Later Chemotherapy in A Community Oncology Setting in The United States

    Nov 1, 2016, 00:00

  • Social Media- A Valuable Tool to Assess Patient Perspectives Regarding Quality of Life

    Nov 1, 2016, 00:00

  • Availability And Costs Of Pediatric Formulations In India - A Case Study

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Secukinumab In Moderate To Severe Plaque Psoriaris, Ankylosing Spondylitis And Psoriatic Arthritis In France

    Nov 1, 2016, 00:00

  • The Trend of High Dose Insulin Initiated Among Diabetes Patients in UK

    Nov 1, 2016, 00:00

  • Attitude towards the use of complementary and alternative medicines (cam) among pharmacy and medical students. A comparative study

    Nov 1, 2016, 00:00

  • Long-Term Visual Functioning Improvement is Associated with Resolution of Vitreomacular Adhesion in Subjects with Vitreomacular Traction, Including Macular Hole Treated with Intravitreal Ocriplasmin- Results From The Oasis Study

    Nov 1, 2016, 00:00

  • Disease Burden of Herpes Zoster in Taiwan- A Five-Year Population-Based Study

    Nov 1, 2016, 00:00

  • Do Nutrition Interventions Require a Different Approach to Economic Evaluation?

    Nov 1, 2016, 00:00

  • Rescaling The Overall Score In The Cervantes Short-Form Scale For Measuring Health-Related Quality Of Life In Menopausal Women Sexually Inactive

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Screening for Severe Sleep-Disordered Breathing in Japan

    Nov 1, 2016, 00:00

  • Access To Anti-Infective Medicines For Systemic Use In Armenia

    Nov 1, 2016, 00:00

  • Burden of Disease and Healthcare Costs of Patients Treated with Antiglaucoma Drugs

    Nov 1, 2016, 00:00

  • Have the NHS Health Checks been Unfairly Maligned?

    Nov 1, 2016, 00:00

  • Cost-Related Medication Nonadherence Among Elderly Medicare Cancer Survivors Using Erythropoiesis-Stimulating Agents

    Nov 1, 2016, 00:00

  • Productivity Loss of Rheumatoid Arthritis Patients By Their Level Of Disease Activity Score

    Nov 1, 2016, 00:00

  • Perceptions of Thalassemia Patients' on Thalassemia and Its Treatment- A Qualitative Exploration

    Nov 1, 2016, 00:00

  • Impact Of Burdensome Chronic Conditions On Health-Related Quality Of Life Among Europeans- Analysis Of Eq-5d-5l Vas Scores

    Nov 1, 2016, 00:00

  • Cost-Efficiency Of Clinical Pharmacy Services At Ministry Of Health In Saudi Arabia Application Of American Model

    Nov 1, 2016, 00:00

  • Knowledge of Blood Pressure Control Programs In University Students

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Using Pazopanib in First-Line Treatment in Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • The Current Treatment of Parkinson's Disease in Japan

    Nov 1, 2016, 00:00

  • Use Of Electronic Health Information Systems (Ehis) By Healthcare Professionals (Hcps) And The Perception Of Its Value In Reducing Medication Risks And Safety For Patients

    Nov 1, 2016, 00:00

  • Identification of Adverse Events In Coronary Artery Disease Patients Based on Health-Related Quality of Life Outcome Data

    Nov 1, 2016, 00:00

  • Key Aspects in the Modelling of Dengue Transmission- Results from a Focused Literature Review

    Nov 1, 2016, 00:00

  • Cancer Drugs in The EU5 and USA- Cross-Country Pricing Comparison and Correlation Analysis Between Overall Survival (OS) and Progression-Free Survival (PFS)

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Incobotulinumtoxin-A With Flexible Treatment Intervals Compared To Fixed Treatment Intervals In The Management Of Blepharospasm And Cervical Dystonia

    Nov 1, 2016, 00:00

  • The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Greece. “RECAP-DM”

    Nov 1, 2016, 00:00

  • Differences in Perception of Health-Related Quality of Life Associates to Socioeconomic, Cultural and Housing Factors- Multilevel Analysis

    Nov 1, 2016, 00:00

  • Excess Costs Associated With Obstructive Sleep Apnea In The Elderly

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Long Acting Granulocyte Colony–Stimulating Factor for Primary Prophylaxis of Febrile Neutropenia in Breast Cancer in The Russia

    Nov 1, 2016, 00:00

  • Frequency of Occurance of Myocardial Infarction in Hungary Between 2004-2012

    Nov 1, 2016, 00:00

  • Budget Impact Model of Secukinumab In The Treatment of Ankylosing Spondylitis (AS) And With Psoriatic Arthritis (PSA) In Italy

    Nov 1, 2016, 00:00

  • Case Duration As A Surgical Quality And Efficiency Indicator In Surgical Residency Training Programs

    Nov 1, 2016, 00:00

  • How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HAS

    Nov 1, 2016, 00:00

  • Manufacturers’ And Pharmacists’ Satisfaction with Different Pharmaceutical Distribution Models in Europe

    Nov 1, 2016, 00:00

  • Olokizumab Treatment of both Western and Asian Patients with Rheumatoid Arthritis who have Failed Anti-Tnf Treatment Results in Sustained Improvements in Patient-Reported Outcomes

    Nov 1, 2016, 00:00

  • The Impact on Access to Innovative Drugs of The First Managed Entry Agreements in Romania

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment of Nintedanib For The Treatment of Idiopathic Pulmonary Fibrosis In The Greek Healthcare System

    Nov 1, 2016, 00:00

  • Non-Adherence to Antihypertensive Drugs- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Impact Of Us Health Exchanges (Hix) On The Pharmaceutical Industry

    Nov 1, 2016, 00:00

  • A Model-Based Cost-Effectiveness Analysis of B-Type Natriuretic Peptide Monitoring in Patients with Heart Failure

    Nov 1, 2016, 00:00

  • Systematic Review of the Value of Safety-Engineered Devices in Reducing Needlestick and Sharps Injuries

    Nov 1, 2016, 00:00

  • Economic Evaluation of Targeted Therapies in Metastatic Clear Renal Cell Carcinoma in Canada

    Nov 1, 2016, 00:00

  • Standardisation and Compatibility Between HTA Networks- what Impacts on Quality?

    Nov 1, 2016, 00:00

  • The Transparency Of Published Recommendations On Reimbursement Of Health Technologies In Poland

    Nov 1, 2016, 00:00

  • Social And Economic Value of Portuguese Community Pharmacies In Public Health

    Nov 1, 2016, 00:00

  • Is utilization of Adjuvant Endocrine Therapy Affected Mainly by Patient Drug Costs? An Analysis of Two Databases

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Mechanical Thrombectomy Using Stent-Retriever After Intravenous T-PA Compared with Intravenous T-PA Alone in The Treatment of Acute Ischemic Stroke Due to Large Vessel Occlusion in Spain

    Nov 1, 2016, 00:00

  • Reasons for Switching Treatment Among Severe Hemophilia A and B Adults in Europe

    Nov 1, 2016, 00:00

  • Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in the UK Setting

    Nov 1, 2016, 00:00

  • Evaluation of the Effect of Pharmacogenetic Dosing of Warfarin- Should Non-Randomized Clinical Studies be Considered?

    Nov 1, 2016, 00:00

  • For Estimating Costs in Patients Experiencing Cardiovascular Events Using Utilization Data From The United Kingdom

    Nov 1, 2016, 00:00

  • Epidemiology and Costs of Psoriasis in Germany – A Retrospective Claims Data Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Prevenar 13 In Children In Portugal

    Nov 1, 2016, 00:00

  • Medication Safety Warnings- Awareness, Source and Actions of Consumers in the U.S

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Telemonitoring in Gynaecology and Obstetrics

    Nov 1, 2016, 00:00

  • Estimating the Economic Burden of Hypoglycemia in Patients with Type 1 and Type 2 Diabetes Mellitus in Austria

    Nov 1, 2016, 00:00

  • The Impact of Regional Cost-Saving Initiatives on the Uptake of Antiretroviral Drugs in London

    Nov 1, 2016, 00:00

  • Impact Of Patients Counselling On Mindful Attention Awareness And Stress In Cancer Patients

    Nov 1, 2016, 00:00

  • Stakeholders Views On The Role Of Hta And Rsas In Pharmaceutical Policy In Greece

    Nov 1, 2016, 00:00

  • Cost Consequence Analysis of Sitagliptin +Metformin Vs Sulfonylureas+Metformin in Type 2 Diabetic Patients in Italy

    Nov 1, 2016, 00:00

  • Evaluating Therapeutic Treatments for Psoriatic Arthritis- Can We Make Better use of Patient Data Registries?

    Nov 1, 2016, 00:00

  • Kangaroo Mother Care- A Cost Effective and an Alternate Method to Manage Hypothermia in Low Birth Weight Babies for Better Clinical Outcome

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness of Dulaglutide Versus Liraglutide in Patients with Type 2 Diabetes Mellitus in Taiwan

    Nov 1, 2016, 00:00

  • Burden of osteoporosis-related hip fracture in asia. A review of health care costs and resource utilization

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Neoadjuvant Pertuzumab and Trastuzumab in Patients with Locally Advanced, Inflammatory, or Early HER-2 Positive Breast Cancer

    Nov 1, 2016, 00:00

  • The Uk Early Access To Medicines Scheme- A 2-Year Status Update On Successes, Issues And Controversies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pazopanib Compared to Sunitinib In the Treatment of Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) In Turkey- A Panel Approach

    Nov 1, 2016, 00:00

  • Exploring The Impact of Adding A Respiratory Dimension to The EQ-5D-5L

    Nov 1, 2016, 00:00

  • Construct Validity Of The 10-Year Time Trade-Off Method In Psoriasis Patients

    Nov 1, 2016, 00:00

  • Prescribing Behaviour And Drug Use In Pakistan

    Nov 1, 2016, 00:00

  • Comparison Of Time To Reimbursement Decision Of Innovative Pharmaceuticals In Europe

    Nov 1, 2016, 00:00

  • Benefit Assessment of Medical Devices of High Risk Classes in Germany- Adaptive Approaches to Balance Early Access and Safety and Efficacy Required?

    Nov 1, 2016, 00:00

  • Quantifying the Health Economic Value Associated with Unit Changes in HBA1C in Type 1 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Ankylosing Spondylitis is Associated with Significant Increases in Healthcare Resource Utilization And Costs in A German Real World Setting

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Empagliflozin (Jardiance) in the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM) in the UK Based on Empa-Reg Outcome Data

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in the UK

    Nov 1, 2016, 00:00

  • Costs of Adverse Events Associated with Cancer Therapies in Non-Small Cell Lung Cancer in France

    Nov 1, 2016, 00:00

  • Clinical and Economic Outcomes of Pharmacist-Provided Home-Based Medication Review in the Elderly- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Direct Costs Associated to Meningococcal Disease and Related Sequelae in Children – Analysis Based on the Brazilian Public Health System Perspective

    Nov 1, 2016, 00:00

  • Cost - Effectiveness Analysis of Presepsin Compared with C-Reactive Protein and Procalcitonin in Detecting Severe Bacterial Infection in Children Aged 29 Days to 36 Months Old with Fever Without Source

    Nov 1, 2016, 00:00

  • Assessing Real Consumption of Medications for Fertility Treatments in Ukraine

    Nov 1, 2016, 00:00

  • Programme Budgeting Marginal Analysis for the Real World- The ‘Prudent Pbma’

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Panitumumab Compared with Cetuximab in the First-Line Treatment of Wild-Type RAS Metastatic Colorectal Cancer Patients in Brazil

    Nov 1, 2016, 00:00

  • A New Approach to Presenting Health States in Stated Preference Valuation Studies

    Nov 1, 2016, 00:00

  • The Management and Costs of Multiple Myeloma in Gree Mapping the Local Treatment Pathway and Associated Resource Use

    Nov 1, 2016, 00:00

  • EQ-5D Utility Value Sets for Sri Lanka- A Case For Economic Evaluations in South Asia

    Nov 1, 2016, 00:00

  • Understanding the Utility Value of Patients with Heavily Pre-Treated Multiple Myeloma

    Nov 1, 2016, 00:00

  • Impact of Diabetes Management on Diabetes Control and Resource Consumption in Type 2 Diabetic Patients

    Nov 1, 2016, 00:00

  • Comparisons of Treatment Patterns for Type 2 Diabetes Mellitus (T2DMm) in Japan and in the United States

    Nov 1, 2016, 00:00

  • Psychometric Properties of The Chinese Version of Problem Areas In Diabetes Scale (Sg-Paid-C) Among High-Risk Polypharmacy Patients With Uncontrolled Type 2 Diabetes In Singapore

    Nov 1, 2016, 00:00

  • Cost Assessment Of Antibiotics Use In A Hospital In The Dominican Republic

    Nov 1, 2016, 00:00

  • European Comparison of Spinal Surgery Hospitalizations From 2010 to 2013 According to Patient Profiles

    Nov 1, 2016, 00:00

  • External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous Melanoma

    Nov 1, 2016, 00:00

  • Current Status of Endoscopic Submucosal Dissection Treatment for Gastric Adenoma in Korea- Based on National Claims Database

    Nov 1, 2016, 00:00

  • Private and Catastrophic Health Expenditure of Patients with Early and Locally Advanced Breast Cancer in Greece

    Nov 1, 2016, 00:00

  • Clinical and Economic Impact of Improving Adherence to Diabetes Treatment In Patients with Type 2 Diabetes in Spain

    Nov 1, 2016, 00:00

  • Integration Of Basic Attention To The Specialized Attention Network In Brazil’s Health System

    Nov 1, 2016, 00:00

  • Comparison Of Biosimilar Guideline And Real Consumption Among Italian Regions

    Nov 1, 2016, 00:00

  • Assessment Of General Knowledge Concerning Health-Related Topics

    Nov 1, 2016, 00:00

  • Efectiveness and Inequality Estimation of Antihypertensive Medicinies` Utilization in Iran According to Observational Data- 2002-2011

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of A Preventive Testing Strategy in Relatives of Patients with BRCA Mutated Ovarian Cancer Versus A No Test Strategy

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilization (HCRU) in Relapsed/Refractory Multiple Myeloma (RRMM)- Comparison of EU and US Cohorts in the Preamble Study

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation of Amoxicillin-Clavulanic Acid in Csom Patients in a South Indian Hospital- A Retrospective Analysis

    Nov 1, 2016, 00:00

  • Validating The Projected Mortality Rates Used in Oncology Cost-Effectiveness Analysis- A Pitfall of Simple Benchmarking With Life Table Age-Specific Mortality Rates for A Trial Population

    Nov 1, 2016, 00:00

  • Guidance On Selecting Appropriate Methods When Considering Adjusting Overall Survival For Treatment Switch In Oncology Studies

    Nov 1, 2016, 00:00

  • Linkage Of The Pharmo Database Network And The Netherlands Perinatal Registry To Construct A Cohort That Captures Pregnancy And Postnatal Outcomes

    Nov 1, 2016, 00:00

  • Network Meta-Analysis of Randomized Trials to Compare the Efficacy of Nsaids, Statins and Vitamins in Alzheimer's Disease

    Nov 1, 2016, 00:00

  • Application Of Quality Indicators To Enable Economic Evaluation Of Quality Improvements – A Bayesian Decision Theoretical And Value Of Information Analytical Framework

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Omalizumab for the Treatment of Chronic Spontaneous Urticaria in France

    Nov 1, 2016, 00:00

  • Assessing the Broader Economic Consequences of Hpv Prevention in Indonesia Using a Government Perspective Fiscal Analytic Method

    Nov 1, 2016, 00:00

  • Economic Impact Of Adverse Drug Reactions- A Pubmed Based Study

    Nov 1, 2016, 00:00

  • Synthesis of Binary Outcome Data on the Log-Odds and Absolute Risk Scales – A Case Study in Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • Costs of Care Between Resected and Non-Resected Pancreatic Cancer Patients- Findings from a Real-World U.S. Population

    Nov 1, 2016, 00:00

  • Higher Weight, Higher Burden- Outcomes Of Adults In Japan With Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Cost Analysis Of Raltegravir Versus Atazanavir/R Or Darunavir/R For Treatment-Naive Adults With Hiv-1 Infection In Spain

    Nov 1, 2016, 00:00

  • Risk Elements and Drug Utilization in Stroke Patients

    Nov 1, 2016, 00:00

  • Cancer Immunotherapy with Checkpoint Inhibitors is Associated with Immune-Mediated Reactions- A Pharmacovigilance Study

    Nov 1, 2016, 00:00

  • Prescription Patterns And Costs Of Migraine Therapy In Germany

    Nov 1, 2016, 00:00

  • Temperature, Real Time, on Site, Potency Monitoring Studies of Different Brands of Cephalexin Tablets Stored in Hospital and Community Pharmacies in Different Part of Kerala

    Nov 1, 2016, 00:00

  • Burden of Non-Tuberculous Mycobacterial Pulmonary Disease In Germany Based on Sick Fund Data Analysis

    Nov 1, 2016, 00:00

  • Managed Entry Agreements- Portuguese Experience

    Nov 1, 2016, 00:00

  • Adherance To Medication Errors Repoting System At Public Hospital, Riyadh, Saudi Arabia

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Using Pazopanib-Everolimus in First and Second Line of Treatment, In Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Adding Bedaquiline To Background Drug Regimens For The Treatment of Multidrug-Resistant And Extensively-Resistant Tuberculosis In Italy

    Nov 1, 2016, 00:00

  • Ict Diffusion and Pharmaceuticals (Issues For Decision Tools)

    Nov 1, 2016, 00:00

  • Not All Cochrane Reviews Are Good Quality Systematic Reviews

    Nov 1, 2016, 00:00

  • HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision-Making in Catalonia (Spain)- Pilot Study Focused in Orphan Drugs

    Nov 1, 2016, 00:00

  • Outcomes for Older Patients with Acute Myeloid Leukemia (AML)- Multiple Hospitalizations and High Mortality Rates

    Nov 1, 2016, 00:00

  • Evaluation of Methodological Variations in the Event Simulation Approaches of Published Health Economic Models in Obesity Prevention and Therapy

    Nov 1, 2016, 00:00

  • Determining Criteria and Weights for Prioritising Health Technologies Based on the Preferences of the General Population- A New Zealand Pilot Study

    Nov 1, 2016, 00:00

  • Development of a Patient-Reported Outcome Measure for Chronic Hypoparathyroidism

    Nov 1, 2016, 00:00

  • The Assessment of Value for Medical Devices- Using Real World Evidence (RWE) to Quantify Unmet Needs in Diabetes Management

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Bevacizumab Compared to Cetuximab and Panitumumab in First-Line Treatment of Kras Wild-Type Metastatic Colorectal Cancer in France

    Nov 1, 2016, 00:00

  • Household Cost Of Injuries in Children Under Five Years in the Ejisu-Juabeng Municipality of the Ashanti Region, Ghana- A Cross Sectional Study

    Nov 1, 2016, 00:00

  • Effects Of Pharmacist Counseling on Outpatients Receiving Warfarin at Dr. Hasan Sadikin Bandung Hospital

    Nov 1, 2016, 00:00

  • Comorbidites and Patient-Reported Outcome after Total Hip Arthroplasty

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Using Everolimus or Axitinib in Patients with Metastatic Renal Cell Carcinoma WHO Have Failed to Use of Pazopanib or Sunitinib in First-Line Treatment

    Nov 1, 2016, 00:00

  • Discharge Prescription Patterns of Antipsychotics In Patients With Mental Illness Hospitalized Compulsorily By Prefectural Governors

    Nov 1, 2016, 00:00

  • Do We Really Know when We Should Screen for Hepatitis B C before Starting Immunosuppressive Therapy ?

    Nov 1, 2016, 00:00

  • Direct Costs and Healthcare Resource Use Associated with Advanced Non-Small Cell Lung Cancer Management in Previously Treated Patients in Portugal

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Evaluation of Tips Procedures with Expanded Polytetrafluoroethylene (EPTFE) Covered Stent-Grafts Compared to Large Volume Paracentesis in Patients with Refractory Ascites – A Spanish Scenario

    Nov 1, 2016, 00:00

  • Improving Access to Psychological Therapies in British Sign Language (BSL)- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Four Decades of Rasch Analysis on Patient-Reported Outcomes Instruments Validation- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • A Population Based Diabetes Drug Utilization Analysis in Chinese Community- A Retrospective Database Study

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis- A Comparison Between Preset Artery Blood Samplers and Disposable Syringes in Arterial Blood Sampling

    Nov 1, 2016, 00:00

  • The Cost-Effectiveness Of Delayed Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Mexican Social Security Institute (Imss)

    Nov 1, 2016, 00:00

  • Setting Recommendations for Good Practice of Health Technology Assessment in the Egyptian Ministry of Health

    Nov 1, 2016, 00:00

  • Clinical Trials Scenario In Brazil- Study And Sponsor Profiles

    Nov 1, 2016, 00:00

  • Work Productivity Activity Impairment Loss of Patients with HER2 Metastatic Breast Cancer

    Nov 1, 2016, 00:00

  • Direct Cost Of Hiv/Aids In Turkey

    Nov 1, 2016, 00:00

  • The Cancer Drugs Fund- Past, Present and Future

    Nov 1, 2016, 00:00

  • Implementation Of The Insurance Programs For Catastrophic Diseases In China- A Qualitative Study

    Nov 1, 2016, 00:00

  • In-Hospital Mortality and Complications Following Surgical Resection of Glioblastoma

    Nov 1, 2016, 00:00

  • Personalized Mammography Screening and Screening Adherence - A Simulation of Cost-Effectiveness

    Nov 1, 2016, 00:00

  • Specialty Pharmacy, Diagnostic, And Genetic Testing Coverage In The United States

    Nov 1, 2016, 00:00

  • Icpc-2 Episode-Based Health-Related Quality Of Life And Three Months Effectiveness In Three Finnish Primary Health Care Settings

    Nov 1, 2016, 00:00

  • The Impact of the Difference in Natural History Models on the Cost-Effectiveness of Antiviral Agents for Patients with Genotype 1 Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • A Unique Opportunity To Assess Quality-Of-Life Changes In Long-Term Waitlisted Bariatric Surgery Patients Using The Eq-5d-5l And Aqol-8d Multi-Attribute Utility Instruments Before And Three Months After Bariatric Surgery- An Exploratory Stu ...

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Abatacept, Tocilizumab, And Tnf-Inhibitor Compared With Rituximab As A Second-Line Therapy For Treatment of Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • The GM Ahsn Af Landscape Tool- A Shared Data Platform to Identify Health and Economic Opportunities to Reduce Incidence of Stroke Through Effective Anticoagulant Management of Patients with Atrial Fibrillation in Greater Manchester

    Nov 1, 2016, 00:00

  • Nothing Ventured, Nothing Gained – Is The Innovation Fund The Catapult to A New Generation of Care Concepts and A Competitive Market in Health Care in Germany?

    Nov 1, 2016, 00:00

  • Adjusting Variance Parameters to Incorporate Uncertainty into Health Economics Models Following Treatment Switching

    Nov 1, 2016, 00:00

  • Validation Of Comorbidity Indices (Charlson And Elixhauser) Computed In Cross Sectional Hospital Billing Data

    Nov 1, 2016, 00:00

  • Application of Value of Information Analysis To Minimize Decision Risk In Malaysia

    Nov 1, 2016, 00:00

  • Mapping of Existing Data Sources for the Conduct of Real-World Studies on Lung Cancer in China

    Nov 1, 2016, 00:00

  • Parallel Export And Its Impact On Availability Of Drugs In Slovakia

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Indonesian Asthma Patients

    Nov 1, 2016, 00:00

  • Evaluating the Effectiveness of Treatments of Opioid use Disorder Based on Recovery Outcomes- How to Bridge the Disconnect Between Clinical Trial Outcomes and Recovery Outcomes?

    Nov 1, 2016, 00:00

  • Towards Improved Cervical Cancer Primary Screening in Austria - A Decision-Analytic Benefit-Harm Analysis

    Nov 1, 2016, 00:00

  • EQ-5D Studies in Rheumatology in Eight Central and Eastern European Countries

    Nov 1, 2016, 00:00

  • The First Indonesian Health-Related Quality of Life Valuation Study- An Eq-5d-5l Value Set

    Nov 1, 2016, 00:00

  • Racial/Ethnic Disparity in Individual Economic Burden of Diabetes in the USA

    Nov 1, 2016, 00:00

  • A Retrospective Premier Database Study to Evaluate Differences Between Progel™ Pleural Air Leak Sealant As Compared with Other Sealants in The Inpatient Surgical Setting

    Nov 1, 2016, 00:00

  • Market Uptake Of Pharmaceutical Innovations In Germany - Regulatory Approaches And Its Consequences

    Nov 1, 2016, 00:00

  • General Public Knowledge and Awareness About Medicines Use in Penang, Malaysia

    Nov 1, 2016, 00:00

  • A Health Outcomes Model Showing Stroke Prevention in Atrial Fibrillation and Cost-Savings in England

    Nov 1, 2016, 00:00

  • Markov Models For Health Economic Evaluation Modelling In R With The Heemod Package

    Nov 1, 2016, 00:00

  • Achieving Optimal Fit-To-Survival Data Using Cubic Spline Models- A Case-Study Comparing The Fit of Standard and Cubic Spline Models to Survival Data from the Icon6 Study

    Nov 1, 2016, 00:00

  • Direct Economic Burden in Patients with Cerebral Venous Thrombosis at A Tertiary Care Hospital in South India

    Nov 1, 2016, 00:00

  • The Influence Of Price Regulation Method On Price Trajectory – Assessment Of Cancer Drug Prices In Usa, The Uk And Israel

    Nov 1, 2016, 00:00

  • Treatment Patterns And Drug-Related Costs For Patients with Psoriasis on Biologic Therapy- A Retrospective Cohort Study In Southern Italy

    Nov 1, 2016, 00:00

  • Changing Patterns of Medication Use at the End of Life in the Elderly

    Nov 1, 2016, 00:00

  • Analysis on the Regional Distribution of Telemedicine in China

    Nov 1, 2016, 00:00

  • Impact of Medication Therapy Management Service Provided by Clinical Pharmacists on Drug Therapy of Patients Undergoing Hemodialysis

    Nov 1, 2016, 00:00

  • Exploring The Socioeconomic Impact Of Post Approval Change Requirements For Vaccines

    Nov 1, 2016, 00:00

  • Incremental Cost-Effectiveness of Algorithm-Driven Genetic Testing Versus no Testing for Maturity Onset Diabetes of the Young (Mody) in Singapore

    Nov 1, 2016, 00:00

  • An Observational Study on Risk Factors and Clinical Presentation S In Stroke Patients

    Nov 1, 2016, 00:00

  • Evaluation Of The Impact Of Pharmacists Qualification And Years Of Practice On Pharmaceutical Care Services In Community Pharmacy Practice In Enugu Nigeria

    Nov 1, 2016, 00:00

  • Prevalence of Therapy-Resistant Hypercholesterolemia in High-Risk Cardiovascular Patients in Germany

    Nov 1, 2016, 00:00

  • Psychometric Properties Of The Finnish Version Of The Lower Extremity Functional Scale Among Foot And Ankle Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apixaban for The Treatment of Atrial Fibrillation Patients in The Kingdom of Saudi Arabia

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis To Estimate The Cost Savings from Alectinib on Patients With Anaplastic Lymphoma Kinase (ALK) Positive Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) Previously Treated with Crizotinib

    Nov 1, 2016, 00:00

  • Assessment of Criteria Influences on Judicious Selection of New Drug for Future Coverage Policy in Iran- An Analysis with Structural Equation Modeling

    Nov 1, 2016, 00:00

  • Assessing The Clinical And Economic Burden of Prostate Cancer in The United States Veteran Population

    Nov 1, 2016, 00:00

  • Clinical Impact of Antimicrobial Impregnated Catheters For Reduction of Infection In Cerebrospinal Fluid Diversion Procedures

    Nov 1, 2016, 00:00

  • Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Axial Spondyloarthritis Patients, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis- 4-Year Outcomes from the Rapid-Axs ...

    Nov 1, 2016, 00:00

  • Utilisation and Dosage Patterns of Intravenous Echinocandins for Treatment of Invasive Fungal Infections Within Hospitals in England

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in Egypt

    Nov 1, 2016, 00:00

  • UK Cost-Effectiveness Analysis for Management of CMV Disease in Patients Post Allogeneic Stem Cell Transplantation with a Novel Adoptive T Cell Therapy

    Nov 1, 2016, 00:00

  • Geographic, Racial, and Temporal Variations of Adherence to Screening for Cervical Cancer and HPV Vaccination in The United States, 2008-2012

    Nov 1, 2016, 00:00

  • Indirect Treatment Comparison of Ustekinumab Versus Other Biologics In Moderate To Severe Crohn’s Disease- A 1-Year Treatment Sequence Analysis

    Nov 1, 2016, 00:00

  • Treatment Rates in Patients with HER2+ Metastatic Breast Cancer and the Factors Influencing Treatment Decision

    Nov 1, 2016, 00:00

  • The Impact of Duration on EQ‐5D‐5l Value Sets Derived from a Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • The Short-Term Health and Economic Burden of Gestational Diabetes Mellitus in Italy

    Nov 1, 2016, 00:00

  • Real-World Health Outcomes, Economic Impacts, and Cost-Effectiveeness of a Beijing Municipal Government Funded Free-Drug Rpogram in Community Schizophrenia Patients in Beijing, China

    Nov 1, 2016, 00:00

  • Burden of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Turkey

    Nov 1, 2016, 00:00

  • Assessing Health-State Utility Values in Australian People with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • A Network Meta-Analysis of Atomoxetine, Methylphenidate, Lisdexamfetamine, and Bupropion for the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes in Spondyloarthritis Patients in Europe- A Systematic Review of the Literature

    Nov 1, 2016, 00:00

  • Different Methods, Different Results? Comparing Health Technology Assessments in the United Kingdom and Germany

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Laparoscopic Surgery For Presumed Leiomyomas

    Nov 1, 2016, 00:00

  • Is There a Justification to Fullfill the Gap in Clinical Pathway of Inflammation and Itching Treatment in Poland - Cost-Utility Analysis (CUA) of Mometasone Furoate Ointment

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Lanreotide Autogel 120 Mg in the Treatment of Acromegaly in Poland

    Nov 1, 2016, 00:00

  • Added Benefit of Upper Airway Stimulation For The Treatment of Moderate To Severe Obstructive Sleep Apnea In Austria

    Nov 1, 2016, 00:00

  • The Evolution And Comparison Of Hta Assesment Organisations In Selected European Countries

    Nov 1, 2016, 00:00

  • Health Status in Patients with Severe Haemophilia a According to Treatment Regimen and Age

    Nov 1, 2016, 00:00

  • Assessment of Carotid Stenting Safety- A French Exhaustive Cohort Study Based on The Re-Use of Routine National Health Database

    Nov 1, 2016, 00:00

  • Investigating The Economic Impact of Sflt-1/PLGF Ratio As A Predictive Test in Women with Suspected Preeclampsia in Italy

    Nov 1, 2016, 00:00

  • The Patient-Risk of Hypoglycaemia As A Function of Pharmacological Treatments. A Retrospective Analysis on Database Hypothesis

    Nov 1, 2016, 00:00

  • Reliability and Validity of the Health Assessment Questionnaire (Haq) in Patients with Spondyloarthritis

    Nov 1, 2016, 00:00

  • The Cost of Cognitive Impairment in Patient with Major Depressive Disorder

    Nov 1, 2016, 00:00

  • The Role of Insulin-Like Growth Factor-1 on Steatohepatitis

    Nov 1, 2016, 00:00

  • Economic and Humanistic Impact Assumptions for Hypoglycemic Events- Implications for Cost-Effectiveness Analyses in Insulin-Treated Diabetes

    Nov 1, 2016, 00:00

  • Management and Outcomes of Acute Kidney Injury

    Nov 1, 2016, 00:00

  • Treatment Indications for Antidepressants Prescribed in Primary Care in France, 2006–2015

    Nov 1, 2016, 00:00

  • Pharmaceutical Industry\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany

    Nov 1, 2016, 00:00

  • Using Acoustic Simulations of Hearing Loss to Describe Health States- Are they Feasible and Reliable to use?

    Nov 1, 2016, 00:00

  • A Risk-Benefit Analysis of Key Performance-Based Risk Sharing Agreements (PBRSAS) in the EU and US (2002-2016)

    Nov 1, 2016, 00:00

  • The Clinical and Economic Impact of School-Based Quadrivalent Human Papillomavirus Vaccine on Female or Both Genders in Singapore

    Nov 1, 2016, 00:00

  • The Impact of Medical Insurance Coverage of Imatinib and Molecular Monitoring Frequency on Outcomes in Treatment of Chronic Myeloid Leukaemia (CML)- A Real World Evidence in China

    Nov 1, 2016, 00:00

  • How Much are Chinese Willing to Pay for the Health Improvement?

    Nov 1, 2016, 00:00

  • Clinical Effectiveness of Ranibizumab And Aflibercept For Central RVO- A Retrospective Cohort Study Using Electronic Medical Records From The USA

    Nov 1, 2016, 00:00

  • The Indirect Costs of Breast Cancer in The Slovak Republic

    Nov 1, 2016, 00:00

  • PCSK9-Inhibitors- Identification of Eligible Patients from Regional Administrative Healthcare Databases

    Nov 1, 2016, 00:00

  • Work and Income Loss Consideration Among Patients With Herpes Zoster When Completing A Quality Of Life Questionnaire

    Nov 1, 2016, 00:00

  • Economic considerations on the use of recombinant vs. Plasmatic factor VIII in the treatment of previously untreated haemophilia a patients

    Nov 1, 2016, 00:00

  • Modeling Treatments and Outcomes in Metastatic Castration-Resistant Prostate Cancer- A Case Study of Discrete Event Simulation and the Challenges for A UK Nice Evaluation

    Nov 1, 2016, 00:00

  • Watch Out for Berkson's Bias (BB)! Setting Health-Related Quality of Life (HRQOL) Treatment Targets with Matching-Adjusted Indirect Comparison (MAIC) in Order to Predict Matched General Population Control (MGPC) Targets, Assess Potential to ...

    Nov 1, 2016, 00:00

  • Projected Long-Term Outcomes in Patients with Type 1 Diabetes Mellitus Treated with Faster-Acting Insulin Aspart Versus Conventional Insulin Aspart in the UK Setting

    Nov 1, 2016, 00:00

  • The Increasing Role of Wearable Digital Technology in Disease Management - An Assessment of the Opportunities and Challenges from a Multi-Stakeholder (Patient, Payer, Physician, Manufacturer) Perspective

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Biphasic Insulin Aspart 50 Versus Biphasic Human Insulin 50 in People with Type 2 Diabetes Mellitus in China

    Nov 1, 2016, 00:00

  • Cost Implications Of Inappropriate Prescribing Of Anti-Malarial Therapy For Treatment Of Undifferentiated Febrile Illness Among Elderly

    Nov 1, 2016, 00:00

  • Assessing Primary Care Practice Capacity For Quality Improvement- Preliminary Findings From Healthy Hearts in The Heartland (H3)

    Nov 1, 2016, 00:00

  • Comparison of Three Generic Utility Instruments In Patients With Renal Disease

    Nov 1, 2016, 00:00

  • Universal Mass Vaccination With Phid-Cv Is Cost-Effective In Croatia

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Rfsh And Hp-Hmg For Infertility Treatment In Brazil

    Nov 1, 2016, 00:00

  • A Novel Method for Evaluating Value Assessment Frameworks

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80 (current)
  • »